Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance

por Pelekanou, Vasiliki, Carvajal-Hausdorf, Daniel E., Altan, Mehmet, Wasserman, Brad, Carvajal-Hausdorf, Cristobal, Wimberly, Hallie, Brown, Jason, Lannin, Donald, Pusztai, Lajos, Rimm, David L.
Publicado 2017

Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance

por Pelekanou, Vasiliki, Carvajal-Hausdorf, Daniel E., Altan, Mehmet, Wasserman, Brad, Carvajal-Hausdorf, Cristobal, Wimberly, Hallie, Brown, Jason, Lannin, Donald, Pusztai, Lajos, Rimm, David L.
Publicado 2017

Quantitative and Pathologist-Read comparison of the Heterogeneity of Programmed Death-Ligand 1(PD-L1) expression in Non-Small Cell Lung Cancer

por Rehman, Jamaal A., Han, Gang, Carvajal-Hausdorf, Daniel E., Wasserman, Brad E., Pelekanou, Vasiliki, Mani, Nikita L., McLaughlin, Joseph, Schalper, Kurt A., Rimm, David L.
Publicado 2016

High Concordance of a Closed-System, RT-qPCR Breast Cancer Assay for HER2 mRNA, Compared to Clinically Determined Immunohistochemistry, Fluorescence in situ Hybridization, and Quan...

por Wasserman, Brad E., Carvajal-Hausdorf, Daniel E., Ho, Kenneth, Wong, Wendy, Wu, Natalie, Chu, Victor C., Lai, Edwin W., Weidler, Jodi M., Bates, Michael, Neumeister, Veronique, Rimm, David L.
Publicado 2017